Covidh Technologies Intrinsic Value
Covidh Technologies (COVIDH) median intrinsic value is ₹23.25 from 3 valuation models (range ₹16–₹31), vs current price ₹77.49 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse COVIDH financial statements for revenue, profit, balance sheet and cash flow data.
COVIDH Valuation Methods Summary — DCF, Graham Number & P/E
Covidh Technologies intrinsic value across 3 models vs current price ₹77.49 — upside/downside and value range per method. For current market price and key ratios, visit COVIDH screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹15.50 | ₹13.95 - ₹17.05 | -80.0% | Book Value/Share: ₹0.91, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹23.25 | ₹20.93 - ₹25.58 | -70.0% | Revenue/Share: ₹14.55, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹31.00 | ₹24.80 - ₹37.20 | -60.0% | CF Growth: 5.0%, Discount: 15% |
COVIDH Intrinsic Value vs Market Price — All Valuation Models
Covidh Technologies fair value range ₹16–₹31 vs current market price ₹77.49 across 3 valuation models. Also explore COVIDH stock price history to track price trends across different timeframes.
COVIDH Intrinsic Value Analysis — Undervalued or Overvalued?
Covidh Technologies median intrinsic value ₹23.25, current price ₹77.49 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of COVIDH?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Covidh Technologies (COVIDH) is ₹23.25 (median value). With the current market price of ₹77.49, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹15.50 to ₹31.00, indicating ₹15.50 - ₹31.00.
Is COVIDH undervalued or overvalued?
Based on our multi-method analysis, Covidh Technologies (COVIDH) appears to be trading above calculated value by approximately 70.0%.
COVIDH Financial Health — Key Ratios vs Industry Benchmarks
Covidh Technologies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.12 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.89x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
COVIDH Cash Flow Quality — Operating & Free Cash Flow
Covidh Technologies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2019 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2018 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2016 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2015 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |